MedPath

Ruttonjee Hospital

🇭🇰Hong Kong, China
Ownership
-
Established
1991-01-01
Employees
-
Market Cap
-
Website
http://www.ha.org.hk/visitor/ha_hosp_details.asp?Content_ID=100144&Lang=ENG

Clinical Trials

6

Active:0
Completed:5

Trial Phases

1 Phases

Phase 4:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 4
5 (100.0%)

Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease

Phase 4
Completed
Conditions
Ischemic Heart Disease
Interventions
First Posted Date
2010-09-16
Last Posted Date
2012-06-06
Lead Sponsor
Ruttonjee Hospital
Target Recruit Count
97
Registration Number
NCT01203696
Locations
🇨🇳

Ruttonjee Hospital, Hong Kong SAR, China

Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin

Phase 4
Completed
Conditions
Acute Myocardial Infarction
Acute Coronary Syndrome
Interventions
First Posted Date
2010-02-04
Last Posted Date
2010-10-05
Lead Sponsor
Ruttonjee Hospital
Target Recruit Count
100
Registration Number
NCT01062516
Locations
🇨🇳

Ruttonjee Hospital, Hong Kong, China

Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia

Phase 4
Conditions
Dyspepsia
Aspirin
Interventions
First Posted Date
2009-09-16
Last Posted Date
2012-06-06
Lead Sponsor
Ruttonjee Hospital
Target Recruit Count
128
Registration Number
NCT00978159
Locations
🇨🇳

Queen Mary Hospital, Pokfulam, Hong Kong, China

🇨🇳

Ruttonjee Hospital, Hong Kong, China

Is a Reporting System for Gastritis or Duodenitis (Modified Lanza Scale) Reproducible?

Completed
Conditions
Gastritis
Duodenitis
First Posted Date
2009-02-26
Last Posted Date
2012-06-06
Lead Sponsor
Ruttonjee Hospital
Target Recruit Count
200
Registration Number
NCT00852150
Locations
🇨🇳

Ruttonjee Hospital, Hong Kong, China

Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion

Phase 4
Completed
Conditions
Peptic Ulcer/Erosions
Interventions
First Posted Date
2009-02-13
Last Posted Date
2009-02-13
Lead Sponsor
Ruttonjee Hospital
Target Recruit Count
161
Registration Number
NCT00843063
Locations
🇨🇳

Ruttonjee Hospital, Wan Chai, Hong Kong, China

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.